key: cord-0014777-5usg1onh
authors: Yagnik, Darshna; Ward, Malcolm; Shah, Ajit J.
title: Antibacterial apple cider vinegar eradicates methicillin resistant Staphylococcus aureus and resistant Escherichia coli
date: 2021-01-20
journal: Sci Rep
DOI: 10.1038/s41598-020-78407-x
sha: 3e95018d34f23f49aaea6921a9bf3598b222f402
doc_id: 14777
cord_uid: 5usg1onh

Methicillin-resistant Staphylococcus aureus (MRSA) and resistant Escherichia coli (rE.coli) infections can spread rapidly. Further they are associated with high morbidity and mortality from treatment failure. Therapy involves multiple rounds of ineffective antibiotics alongside unwanted side effects, alternative treatments are crucial. Apple cider vinegar (ACV) is a natural, vegan product that has been shown to have powerful antimicrobial activity hence we investigated whether ACV could ameliorate these resistant bacteria. The minimum dilution of ACV required for growth inhibition was comparable for both bacteria (1/25 dilution of ACV liquid and ACV tablets at 200 µg/ml were effective against rE. coli and MRSA). Monocyte co-culture with microbes alongside ACV resulted in an increase in monocyte phagocytosis by 21.2% and 33.5% compared to non-ACV treated but MRSA or rE. coli stimulated monocytes, respectively. Label free quantitative proteomic studies of microbial protein extracts demonstrated that ACV penetrated microbial cell membranes and organelles, altering the expression of key proteins. This resulted in significant reductions in total protein expression, moreover we could only detect ribosomal proteins; 50 s 30 s, enolase, phosphenol pyruvate and the ATP synthase subunit in rE. coli. Elongation factor iNOS and phosphoglycerate kinase OS were the only proteins present in MRSA samples following ACV treatment.

. ACV is made from an alcoholic fermentation process of a combination of apples, sugar and yeast. The constituents include 5% acetic acid, mother of vinegar enzymes as well as potassium, magnesium and calcium 10, 11 . One of these ingredients acetic acid, has potent antimicrobial properties and has been shown to inhibit planktonic growth of biofilms consisting of A. baumannii and P. aeruginosa on burns 12 . It has also been shown to inhibit yeast cell growth by causing mitochondrial and ribosomal degradation leading to apoptosis 13 . We have previously shown that ACV has strong antimicrobial action against non-resistant E. coli, Candida albicans and Staphylococcus aureus 14 . Therefore, the aim of the present study was to investigate the antibacterial activity of ACV on antibiotic resistant microbes.

To determine the anti-microbial activity of ACV we directly cultured resistant E. coli or MRSA with different concentrations of ACV. Figure 1 shows the inhibition of growth in MRSA and rE. coli after treatment with different concentrations of ACV from (neat or undiluted, 1:2, 1:10, 1:25 v/v of Bragg's liquid ACV or ACV tablets dissolved in water at 200 and 400 µg were used in culture with the microbes). Figure 2 represents light microscopic images of the co-culture of monocytes with both microbes with and without ACV (1:25 dilution) stained with trypan blue. To note there were significantly more monocytes which were alive following ACV addition as well as exposure to microbes. Furthermore, even neat ACV addition to monocytes in culture for 6 h was not toxic to the cells with over 90% monocyte viability. The minimum dose required to restrict growth for MRSA and rE. coli was a 1:25 dilution of Bragg's ACV (0.5% acetic acid). We also compared different doses of commercial ACV oral tablets on the microbes. We tested concentrations in the range 50-400ug/mL in doubling dilutions of the ACV tablets against each microbe. The MIC for ACV tablets was 200 µg/mL for both MRSA and rE. coli respectively ( Table 1 ). All dilutions were carried out using sterile water. We used Braggs ACV for all future experiments at the minimum inhibitory concentration required for each organism.

Upregulation of phagocytic capacity. Monocytes ingest microbes primarily through phagocytosis hence we tested the effects of ACV on this process. Indeed a 21.2%, and 33.5% increase in monocyte phagocytic capacity was observed after MRSA or rE. coli co-culture with ACV (1:25 concentration) respectively and in comparison, to the resting unstimulated monocytes. The results were comparable to commonly prescribed antibiotics to these infections such as clindamycin or trimethoprim. Results are expressed as the mean and SD of three similar experiments (Table 2) .

Proteomic results of rE. coli and MRSA after exposure to ACV. Label free quantitative bottom-up proteomic study of microbes cultured with and without ACV were directly compared. We were able to identify more than 200 proteins of both microbe proteomes (supplement Table 1 ). In ACV treated rE. coli cultures there was an absence of key enzymes together with DNA replication, glycolytic and respiratory proteins. We could only detect a handful of proteins such as ATP synthase subunit, enolase, phosphenol pyruvate and ribosomal proteins 30 s, 50 s ( www.nature.com/scientificreports/ after ACV treatment included phosphoglycerate and chaperone protein elongation factor proteins compared to the total 200 MRSA proteins identified in controls (Table 3 ).

Millions of years of evolution have resulted in bacteria evolving their survival utilising complex mechanisms of drug resistance to avoid killing by antimicrobial agents. ACV has grown in popularity forming the basis of a multitude of commercial health drinks and has been implicated as a cure all for many maladies 15 .

Our previous in vitro study highlighted the anti-inflammatory as well as antimicrobial effect of ACV on nonresistant E. coli, S. aureus and C. albicans 14 . We now extend the antimicrobial activity of ACV against MRSA and rE. coli. ACV inhibition of bacterial growth is comparable to the inhibition shown by trimethoprim and clindamycin which are typical antibiotics used to treat clinical E. coli and MRSA infections respectively 16, 17 . Proteomic analysis of ACV treated resistant E-coli revealed the presence of key ribosomal proteins (30 s, 50 s). Interestingly erythromycin and other macrolide antibiotics can also target ribosomal structures which are involved in elongation structural polypeptides 18 . Perhaps this indicates the robustness of the ribosomal E. coli subunit. The presence of ATP synthase in rE. coli after ACV treatment is significant since ATP synthases are found ubiquitously in energy-transducing membranes of bacteria which are a crucial antibiotic target 19 . ACV could have destroyed the bacteria exposing its membrane where this protein is found. Bacterial enolase and phosphenol pyruvate were also detected following ACV treatment. Both proteins play a key role in bacterial growth and reproduction 20, 21 . On ACV treated MRSA we could only identify two proteins against an extensive array of classified proteins of the MRSA genome. One of which was bacterial elongation factor which is a key translational protein involved in MRSA resistance and a focus of new antimicrobials 22 . The absence of phosphoglycerate kinase in MRSA following ACV addition indicates that ACV can disrupt the glycolytic MRSA pathway 23 . The anti-microbial capabilities of ACV have been verified clinically in a case of vaginal candida 24 . Recently ACV has been shown to have the capability of upregulating key innate immune defense genes in shrimp as well as increasing their growth in vivo following consumption. It has also been shown to support the intestinal shrimp microbiome 25, 26 . A study in which diabetics were given ACV orally found that it increased the activity of antioxidant enzymes such as catalase and dismutase and glutathione peroxidase 27 . This could be an important factor in its antimicrobial attributes. Antibiotic resistant bacteria can cause complications especially in the gut 28 . In fact, it has been shown that loss of colonization resistance can lead to an increase in vancomycin-resistant E. coli predisposing patients to blood sepsis 29 . Hence, any compound which can amplify the innate immune system could be a formidable antidote for these dreaded resistant organisms. Another component of ACV which could account for its antimicrobial action is acetic acid which has been shown to be active at high (1.8%) and low concentrations including 0.3% 12 . In our studies the minimum ideal concentration for activity was a 1:50 dilution which would contain 0.1% acetic acid. Hence acetic acid may not be the only antimicrobial active component in ACV. Low pH can also effectively destroy microbes. ACV is mildly acidic with a pH of 5.6 compared to acetic acid which has a pH of 4.7. We did investigate the effects of strong organic acids such as hydrochloric and sulphuric acid at a range of concentrations on different microbes (results not shown) but did not see the same antimicrobial effects as with ACV. The Table 2 . Effect of ACV on human monocyte phagocytic capacity. In vitro differentiated macrophages were incubated with microbes for 4 h at 37 °C. Cells cultured with microbes with or without ACV were washed and processed for detection on the Beckton Dickinson flow cytometer. An analysis of changes in regional gated profiles and % shift in side scatter was measured. Data is presented as mean ± SD of 3 similar experiments. www.nature.com/scientificreports/ effect of ACV on human blood parameters is scarce. We demonstrate for the first time that ACV did not have any effects on human monocytes in cultures, even after 24 h of direct ACV exposure at high concentrations; verifying that it is not damaging to white blood cells. This is a vital observation since ACV has been consumed as a food supplement for centuries, many people take it daily hence any side effects are important to highlight. ACV had toxic effects on microbes but reassuringly did not affect the integrity of human monocytes in our experiments. To note ACV should be consumed diluted in a little water or juice as it could burn the throat, otherwise no known toxicity or side effects have been reported due to its consumption. A study by Oussaid et al. 2020 investigated the effects of simultaneous glucose and ACV on rats who were fed 2 mL of ACV per kg of their weight for five weeks.

There was an increase in plasma urea levels in the rats that were fed glucose alone but no change in urea levels in ACV treated rats. This demonstrated ACV did not affect kidney function in fact it corrected the urea levels when fed in combination with glucose 29 . We conclude that ACV can have powerful anti-microbial effects directly on resistant E. coli and MRSA. Mode of action seems to involve an alteration in the pathogenic physiology of the microbes. These in vitro results highlight the antimicrobial capacity of ACV. Therefore, this study prompts further clinical research into the efficacy of treating patients infected with resistant bacterial infections with ACV supplementation. ACV could form the core ingredient of a contemporary pharmacological antimicrobial against MRSA and rE. coli.

Chemical reagents, microorganisms, media and culture conditions. Microbial strains: resistant E. coli strain (NCTC 13353) which is highly resistant to cefepime and cefepime-enmetazobactam combination was purchased from LGC Promochem. MRSA strains (ATCC 33591, NCTC8325 resistant to methicillin) were purchased from Public Heath, Colindale, England. U937 cell line CRL-1593.2 was purchased from the American type culture collection.

Reagents. Dulbecco's modified iscoves media, dimethyl-ethyl-sulphonyl-oxide, HANKS balanced salt solution, histopaque, ethanol, phosphate buffered saline, paraformaldehyde, acetone, dithiothreitol, iodoacetamide, trypsin from porcine pancreas of proteomics grade, formic acid, acetonitrile, HPLC-grade water, methanol and Whatman Mini-UniPrep syringeless filter devices (pore size 0.45 µm) were purchased from Sigma Aldrich (Poole, U.K.). TNF-alpha, enzyme linked immunosorbent assays (ELISA's) were purchased from Research and Development Systems (Abingdon, U.K.). Mueller Hinton agar was purchased from Oxoid, UK. Bragg's Apple Cider Vinegar and apple cider vinegar tablets (500 mg) were purchased from Troo healthcare, Colchester, UK.

Cultures of resistant E. coli and MRSA were grown in nutrient media. All cultures were cultivated in a shaking incubator at 37 °C for 24 h overnight prior to use. Mueller Hinton agar (MHA) was prepared by dissolving 38 g in 1 L of distilled water, boiling the mixture for 1 min, after cooling and autoclaving, it was poured into plates. These were left to dry and subsequently stored at 37 °C. All microbial cultures were adjusted to 0.5 McFarland's standard 1.5 × 10 8 CFU/ml and 4 × 10 6 CFU/ml of each organism were used in experiments. Each microbe was swabbed evenly onto plates containing MHA. For sample addition, 100 µL of ACV at varying concentrations was added to the wells which were punched into the agar. The plates were then incubated at 37 °C for 24 h. Zones of inhibition surrounding samples were identified, photographed and measured in mm. Experiments were repeated at least five times.

Ethical approval. All experimental protocols were approved by the Middlesex University Natural Sciences Ethics Committee, UK number 2323. In addition, the methods were carried out in accordance with the relevant guidelines and regulations.

Human mononuclear cell culture as similarly published previously by Yagnik et al. 14 . The human monocyte cell line U937 was used as a source of monocytes purchased from American type culture collection (ATCC). Cells were cultured at a density of 4 × 10 5 /ml with either rE. coli , MRSA or varying concentrations of ACV at counts of 4 × 10 6 CFU/ml respectively for 24 h at 37 °C and 5% CO 2 after which supernatants were collected and analysed for TNF-α secretion using ELISA kits following manufacturer's protocols.

Monocyte phagocytic capacity measurement by flow cytometry. U937cells were cultured at 4 × 10 5 /ml in 24 well plates over a period of two days after which they were incubated with microbes (4 × 10 6 CFU/ ml) for 4 h at 37 °C and 5% CO 2 . Cells were then scraped replenished in ice cold PBS containing 1 mM EDTA, washed and removed from plates. The resultant pellets were fixed in 400 µL of 4% paraformaldehyde and analysed using a FACS Calibur flow cytometer (Beckton Dickinson Immunocytometry Systems, UK and Cell Quest software 2019).

Sample preparation for mass spectrometry analysis as similarly published previously by Yagnik et al. 14 . MRSA and rE. coli was incubated with or without ACV at 1/25 dilution for 24 h at 37 ∘C and centrifuged at 900 rpm, supernatant was removed leaving bacteria pellets. At least 12 sample repeats were used. Bacteria cell pellets were resuspended in cold acetone (600 μL) and centrifuged at 14,800 rpm for 5 min to precipitate protein. The supernatant was removed and 50 mM ammonium bicarbonate (400 μL) was then added to dissolve the extracted proteins. The protein concentration was measured using a nano drop device (Thermo Fisher UK). www.nature.com/scientificreports/ Samples were reduced with 10 mM dithiothreitol (DTT) for 15 min at 56 °C and alkylated with 100 mM iodoacetamide for 30 min at room temperature in the dark. Each sample was then digested with trypsin at 37 °C overnight.

et al. 14 . Tryptic digests were analysed using a Dionex Ultimate 3000 RSLC Nano ultra-high-performance liquid chromatography system coupled to a Q Exactive. Aliquot (15 μL) of tryptic digest was desalted and concentrated using a 5 mm × 300 μm i.d. C18 trap cartridge and solvents composed of a mixture of water and acetonitrile (98:2%, v/v) containing 0.05% TFA (loading solvent A) and a mixture of acetonitrile and water (80:20%, v/v) (loading solvent B) at a flow rate of 20 μL/min was used. The concentrated sample was separated using a binary gradient elution profile composed of a mixture of water and acetonitrile (95:5,v/v) containing 0.1% formic acid (eluent A) and a mixture of acetonitrile and water (80:20%, v/v) (eluent B) containing 0.1% formic acid at a flow rate of 6 μL/min. The gradient was 0 min-0% B, 4 min-5% B, 5 min-8% B, 40 min-40% B, 41 min-80% B. The auto sampler and column oven temperature were set to 4 and 40 °C respectively. The Q Exactive was operated in a data dependent mode. MS survey scans were acquired from m/z 350 to 2000 at resolution of 70,000 with AGC of 3e6 and maximum IT of 100 ms. The 10 most abundant ions were subjected to MS/MS and measured with a resolution of 17,500 and AGC of 1e5 and maximum IT of 200 ms 14 .

Data processing and analysis based on methods similarly published previously by Yagnik et al. 14 . LC-MS/MS data was processed using Proteome Discoverer v2.1 (ThermoFisher Scientific, UK) with database searching against a downloaded FASTA file originating from Uniprot_SwissProt_2019_02. Search parameters were set to match MS/MS spectra to peptides created by fully specific trypsin cleavage within a precursor mass tolerance of 10 ppm and with a fragment mass tolerance of 0.02 Da. Carbamidomethyl (CAM: + 57.021 Da) was set as a static modification to cysteines whereas methionine oxidation (MetOx: + 15.995 Da) was set as a variable modification. Results were initially visualised within the software and then exported to Excel for further review 14 .

Statistical analysis. All experimental results are expressed as the mean ± standard deviation (SD). Statistical analyses were carried out using one way ANOVA or students t-test, outcomes were considered significant where p < 0.05 (when comparing apple cider vinegar treated microbes to the untreated groups in all experiments). All experiments were repeated at least 3-5 times. Analysis was carried out using Excel software version 2019.

The datasets generated and analyzed during the current study can be made available upon request.

Received: 22 February 2020; Accepted: 6 November 2020

World Health Organization (WHO)

Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics

The effect of acute malnutrition on enteric pathogens, moderate-to-severe diarrhea, and associated mortality in the Global Enteric Multicenter Study cohort: A post-hoc analysis

Prediction of surgical site infection in spine surgery from tests of nasal MRSA colonization and drain tip culture

Methicillin-resistant Staphylococcus aureus

Nasal MRSA colonization: Impact on surgical site infection following spine surgery

Waves of resistance: Staphylococcus aureus in the antibiotic era

Celbenin"-resistant staphylococci

A development of alcoholic and malolactic fermentations in highly acidic and phenolic musts

Tackling threats and future problems of multidrug-resistant bacteria

The antibacterial activity of acetic acid against biofilm-producing pathogens of relevance to burns patients

RNA-Seq-based transcriptomic and metabolomic analysis reveal stress responses and programmed cell death induced by acetic acid in Saccharomyces cerevisiae

Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression

Apple cider vinegar modulates serum lipid profile, erythrocyte, kidney and liver membrane oxidative stress in ovariectomized mice fed high cholesterol

Trimethoprim susceptibility in E. coli community-acquired urinary tract infections in France

Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management

Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells

ATP synthase from Escherichia coli: Mechanism of rotational catalysis, and inhibition with the ε subunit and phytopolyphenols

Functional and structural basis of E. coli enolase inhibition by SF2312: A mimic of the carbanion intermediate

Escherichia coli W shows fast, highly oxidative sucrose metabolism and low acetate formation

In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor Tu

Expression, purification, crystallization and preliminary X-ray diffraction studies of phosphoglycerate kinase from methicillin-resistant Staphylococcus aureus MRSA252

Vaginal candidiasis infection treated using apple cider vinegar: A case report

Dietary effect of apple cider vinegar and propionic acid on immune related transcriptional responses and growth performance in white shrimp, Liopenaeus vannamei

Effect of dietary supplementation with applecidervinegar and propionic acid on hemolymph chemistry, intestinal microbiota and histological structure of hepatopancreas in white shrimp, Litopenaeus vannamei

Antidiabetic and antioxidant effects of apple cider vinegar on normal and streptozotocin-induced diabetic rats

Impact of antibiotic-resistant bacteria in the mouse intestine on immune activation and Clostridioides difficile infection

Beneficial effects of apple vinegar on hyperglycemia and hyperlipidemia in hypercaloric-fed rats

D.Y. conceived and performed the experiments, data analysis and wrote the manuscript. MW carried out the proteomic analysis. A.S. contributed to manuscript writing and data review.

The authors declare no competing interests.

Supplementary information is available for this paper at https ://doi.org/10.1038/s4159 8-020-78407 -x.Correspondence and requests for materials should be addressed to D.Y.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.